Literature DB >> 351218

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment.

G L Knatterud, C R Klimt, M E Levin, M E Jacobson, M G Goldner.   

Abstract

The University Group Diabetes Program is a long-term prospective clinical trial designed to evaluate the effects of various hypoglycemic agents on vascular complications in patients with asymptomatic adult-onset diabetes. Mortality and blood glucose levels were determined as well as certain nonfatal events for patients assigned to diet alone or to either of two insulin treatment regimens. Lower levels of blood glucose with mean values close to normoglycemia were achieved in the treatment group in which the insulin dosage was adjusted to achieve normoglycemia compared with the levels achieved in patients treated with diet alone or with a fixed dose of insulin. In spite of differences in blood glucose levels among the treatment groups, there were only minor differences in the occurrence of fatal or nonfatal events.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 351218

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  26 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  The treatment of diabetic kidney disease.

Authors:  F C Goetz; C M Kjellstrand
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

3.  Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.

Authors:  Giovanni Corrao; Silvana Antonietta Romio; Antonella Zambon; Luca Merlino; Emanuele Bosi; Marina Scavini
Journal:  Eur J Clin Pharmacol       Date:  2010-11-19       Impact factor: 2.953

Review 4.  Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment.

Authors:  Paola Terlizzese; Fabrizio Losurdo; Massimo Iacoviello; Nadia Aspromonte
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

5.  Pregnancy glycemia to vascular risk: nonglycemic diabetes?

Authors:  J Kennedy Cruickshank; Moulinath Banerjee
Journal:  CMAJ       Date:  2009-08-24       Impact factor: 8.262

6.  Effect of PHA-B fraction of Agaricus bisporus lectin on insulin release and 45Ca2+ uptake by islets of Langerhans in vitro.

Authors:  N Ahmad; R Bansal; A K Rastogi; J R Kidwai
Journal:  Acta Diabetol Lat       Date:  1984 Jan-Mar

Review 7.  Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.

Authors:  Chee W Chia; Josephine M Egan; Luigi Ferrucci
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

8.  The hypoglycaemic and insulinotropic activity of Tinospora crispa: studies with human and rat islets and HIT-T15 B cells.

Authors:  H Noor; P Hammonds; R Sutton; S J Ashcroft
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

9.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

Review 10.  Glucose control and cardiovascular disease: is it important? No.

Authors:  Ignacio Conget; Marga Giménez
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.